Analysis of the Therapeutic Effect of Abdominal Puncture Combined with Acetic Acid Sustained-release Implant on Chocolate Cysts

Abstract

Abstract: Objective To analyze the therapeutic effect of abdominal puncture combined with acetic acid sustained-release implant on chocolate cysts. Methods 88 cases of patients with chocolate cysts who was diagnosed and treated at a certain hospital from June 2019 to January 2023 was selected as the research subjects. According to a 1:1 random number table method, the 88 patients was divided into a combination group of 44 cases and a control group of 44 cases. The control group was treated with abdominal puncture, while the combined group was treated with acetic acid sustained-release implant on the basis of the control group. Both groups was treated and observed for 5 months to observe and record the patient's prognosis. Results After 5 months of treatment, the total effective rate of the combination group was significantly higher than the control group (P<0.05). After 5 months of treatment, the serum levels of follicle-stimulating hormone and luteinizing hormone in both groups was significantly lower than before treatment (P<0.05). The serum levels of follicle-stimulating hormone and luteinizing hormone in the combined group was also significantly lower than those in the control group after 5 months of treatment (P<0.05). There was no significant difference between the combined group and the control group about the incidence of adverse reactions such as fever, pelvic effusion, bleeding, and urinary retention (P>0.05). The quality of life scores of emotional function, mental health, physiological function, general health status, social function, physiological function, physical pain, and energy in the combination group was significantly higher than those in the control group after 5 months of treatment(P<0.05). Conclusion abdominal puncture combined with acetic acid sustained-release implant can improve the overall treatment effect of patients with chocolate cysts, promote the release of serum follicle-stimulating hormone and luteinizing hormone, reduce the occurrence of adverse reactions, and improve the quality of life of patients.

Key words: abdominal puncture, gonadotropin-releasing hormone analo

CLC Number:

R711.7

XU Yan, ZHAI Yun-fang, NuerAminamu · Rouzi, Dilibeier · Anwaier. Analysis of the Therapeutic Effect of Abdominal Puncture Combined with Acetic Acid Sustained-release Implant on Chocolate Cysts[J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(20): 43-47.

References

[1] 范芳,孔蓓娜.针刺配合GnRH-a治疗卵巢巧克力囊肿剥除术患者的疗效观察[J].中国性科学,2021,30(1):112-115.
[2] 林丽,张汉英,张利.腹腔镜卵巢巧克力囊肿剥除术后应用GnRH-a对患者残留卵巢储备功能及复发率的影响因素分析[J].中国医学工程,2021,29(12):26-30.
[3] 朱丽莉,张建亚.腹腔镜联合针药治疗巧克力囊肿患者的疗效及对血清白细胞介素-6和糖类抗原125水平的影响[J].中国妇幼保健,2021,36(6):1419-1423.
[4] 史寒梅,许敏丹,许燕,等.桂枝茯苓胶囊联合GnRHa对卵巢巧克力囊肿腹腔镜剥除术后康复和卵巢功能的影响[J].中华中医药学刊,2020,38(3):219-221.
[5] 刘新玉,雷喜锋,杨华.腹腔镜手术联合GnRH-a促性腺激素治疗卵巢巧克力囊肿的临床疗效及对患者卵巢功能的影响[J].临床和实验医学杂志,2016,15(11):1114-1116.
[6] 冯晓丹,李岚,郭洁,等.不同剂量米非司酮预防卵巢巧克力囊肿术后复发的临床观察[J].中国妇幼健康研究,2016,27(10):1261-1264.
[7] 李晓平. 小剂量米非司酮联合GnRHa治疗卵巢巧克力囊肿术后疗效观察[J].蚌埠医学院学报,2014,(8):1059-1061.
[8] 马冰倩,李明哲.戈舍瑞林缓释植入剂+腹腔镜手术治疗卵巢巧克力囊肿合并不孕患者的临床效果[J].首都食品与医药,2020,27(11):82-82.
[9] 张琼丽,代燕增,王崇稳,等.卵巢巧克力囊肿的CT诊断与鉴别诊断[J].世界最新医学信息文摘(连续型电子期刊),2021,21(13):258-259.
[10] 杜华文. 卵巢巧克力囊肿患者术后复发的影响因素分析[J].中国妇幼保健,2020,35(15):2774-2776.
[11] 宋海萍,吴艳霞,郝明.醋酸亮丙瑞林与坤泰胶囊联合用于卵巢巧克力囊肿术后的效果观察[J].中国医院用药评价与分析,2019,19(5):585-587.
[12] 曾治华,李燕,周倩羽.腹腔镜手术联合GnRHa治疗卵巢巧克力囊肿伴不孕的临床效果观察[J].海南医学,2019,30(12):1545-1547.
[13] LEE W G, BUTLER G, CARMICHAEL P, et al.Urological and Gynaecological Considerations for the Use of acetic acid sustained-release implant in Transgender and Nonbinary Adolescents: A Narrative Review[J].Eur Urol Focus,2023,9(1): 35-41.
[14] 崔云静,张申华,杨艳华,等.GnRH-a联合腹腔镜手术治疗卵巢巧克力囊肿的疗效观察[J].医学临床研究,2015,(2):376-377,378.
[15] 宋娟,张淑芬,王杰平.GnRH-a给药时机对卵巢巧克力囊肿剥除术患者自然妊娠率的影响[J].安徽医学,2019,40(12):1361-1364.
[16] 谷小梅. 腹腔镜下卵巢巧克力囊肿剥除术联合GnRHa对卵巢功能的影响[J].中国计划生育学杂志,2019,27(2):166-170.
[17] 闫金雨. 活血化瘀祛湿汤在卵巢巧克力囊肿术后的应用[J].中国中医药科技,2019,26(5):754-756.
[18] CHAN I S,HSU T F,SHIH Y C, et al.Maintenance dienogest therapy following adjuvant gonadotropin-releasing hormone agonist treatment after uterus-sparing surgery in adenomyosis: A retrospective cohort study[J].Int J Gynaecol Obstet,2023,161(3):751-759.
[19] CICOGNA S, DELLINO M, MIANO S T, et al.Aggressive Angiomyxoma of the Lower Female Genital Tract in Pregnancy: A Review of the MITO Rare Tumors Group[J]. Cancers (Basel),2023,15(13):223-228.
[20] DOTREMONT H, FRANCE A, HEINRICHS C, et al.Efficacy and safety of a 4-year combination therapy of growth hormone and gonadotropin-releasing hormone analogue in pubertal girls with short predicted adult height[J]. Front Endocrinol (Lausanne),2023,14(9):1113750.